The myeloid-specific leukocyte integrin CD11d encodes the ␣ D subunit for the ␣ D ␤ 2 receptor. A yeast one-hybrid screen showed that a longer isoform of gut-enriched Kruppel-like factor 4 (GKLF) we term GKLFa interacts with the CD11d promoter. Purified GST-GKLFa protein was shown to bind within the ؊61 to ؊44 region that overlaps a binding site for the CD11d transcriptional activators Sp1 and transforming growth factor ␤-inducible early gene-1 (TIEG1). Transfection of GKLF/GKLFa in myeloid cells reduced CD11d promoter activity, whereas, down-regulation of GKLF/GKLFa with small interfering RNAs led to up-regulation of CD11d expression. Differentiation of myeloid cells with phorbol ester led to activation of the CD11d promoter and reduced occupancy of the promoter by GKLF/GKLFa but an increased occupancy by TIEG1 in vivo. Binding of GKLF/GKLFa, Sp1, and TIEG1 to the CD11d promoter in vivo is dependent on their zinc finger DNA binding domains. GKLFa physically associates with the histone deacetylases (HDAC) 1 and 2, and both HDACs are bound to the CD11d promoter in vivo but released after exposure of myeloid cells to phorbol ester suggesting that GKLF/GKLFa recruits HDACs to effect repression.
The leukocyte integrins are membrane glycoprotein receptors that are essential for immune and inflammatory responses via leukocyte cell-cell and cell-extracellular matrix interactions mediated through integrin-ligand interactions (1) (2) (3) (4) (5) . The failure to express sufficient leukocyte integrin receptors leads to severe bacterial and fungal infections in patients (6) . In contrast, prolonged activation of these receptors leads to tissue damage as evidenced during reperfusion of ischemic blood vessels, stroke, atherosclerosis, and autoimmunity (7) .
The four members of the leukocyte integrin family are composed of distinct ␣-subunits encoded by the CD11a (8) , CD11b (9), CD11c (10), and CD11d (11) genes that non-covalently associate with a common ␤-subunit, encoded by the CD18 gene (12) . The CD11a-d genes are differentially expressed in that all leukocytes express CD11a, whereas, CD11b-d expression is generally observed in myeloid cells. With the exception of the CD11d gene, a considerably large number of studies have been conducted into the role and regulation of the leukocyte integrins. This latest leukocyte integrin to be identified is highly expressed on leukocyte subsets including macrophage foam cells and splenic red pulp macrophages (11) , synovial macrophages (13) , and lung alveolar macrophages (14) suggesting that CD11d plays roles in atherosclerosis, phagocytosis of pathogens and senescent erythrocytes, rheumatoid arthritis, and lung injury.
Within the Ϫ100 to Ϫ20 region of the CD11d promoter is a functional binding site for the transcription factors Sp1 and Sp3, which contribute to the cell-specific expression of CD11d (15) . Interestingly, Sp1/Sp3 factors also regulate CD11a-c (16 -18) and CD18 (19) . Adjacent to the Sp1/Sp3 binding sites on these other leukocyte integrin genes are functional sites for other transcription factors (7) including PU.1, GABP␣, GABP␤, c-Jun, c-Fos, and c/EBP, which prompted us to examine whether these or other factors similarly interact within the Sp1/Sp3 binding site of CD11d. In a previous study we reported that transforming growth factor-␤-inducible early gene-1 (TIEG1) 1 binds to a site overlapping the Sp1 site and specifically activates the CD11d promoter in myeloid cells differentiated with phorbol-12-myristate 13-acetate (PMA) (20) . CD11d exhibits biphasic expression in response to PMA in that shorter exposure (24 h ) to 10 nM PMA leads to down-regulation of CD11d expression (15) , whereas longer exposure (48 h) with 100 nM PMA leads to its up-regulation (21) . We showed that activation of the CD11d promoter by PMA is accompanied by increased occupancy of the promoter by TIEG1 (20) . In this current study a longer isoform of gut-enriched Kruppel-like factor 4 (GKLF, KLF4) (22) we term GKLFa was identified in a yeast one-hybrid analysis of the Ϫ100 to Ϫ20 region of CD11d. Transfection analysis revealed that GKLF/GKLFa represses CD11d promoter activity in leukocytes and antisense downregulation of GKLF/GKLFa expression leads to activation of CD11d in myeloid cells. We show using chromatin immunoprecipitation assays (ChIP) that the up-regulation of CD11d in PMA-stimulated myeloid cells correlates with reduced occupancy of the CD11d promoter by GKLF/GKLFa and histone deacetylases (HDAC) 1 and 2 in vivo.
EXPERIMENTAL PROCEDURES
Cell Culture-All cell lines were obtained from American Type Culture Collection (ATCC; Manassas, VA). THP1 (monocytic leukemia), HL60 (promyelocytic leukemia), Jurkat (T-cell leukemia), and IM-9 cells (B-cell multiple myeloma) were grown in RPMI 1640 medium containing 10% fetal calf serum. C3H (embryonic mouse), Hep G2 (hepatocellular carcinoma), and PA-1 (teratocarcinoma) cells were grown in Dulbecco's modified Eagle's medium containing 10% fetal calf serum.
Yeast One-hybrid Analysis-A yeast one-hybrid screen was performed as described (20) . Briefly, a yeast strain containing integrated reporter plasmids pHisi-1 and pLacZi (Clontech, Palo Alto, CA) that each contain four copies of the Ϫ100 to Ϫ20 region of the CD11d promoter was transformed with a human spleen cDNA library (Clontech, cat. no. HL4054AH) and plated on 45 mM 3-amino-1,2,4-triazole (3-AT). Plasmids recovered were sequenced and analyzed by a BLAST search of GenBank TM . Plasmids-The luciferase (luc) reporter CD11d-(Ϫ173/ϩ74)-luc (15) contains the Ϫ173 to ϩ74 region of the CD11d promoter fused to luc in pGL3-Basic (Promega Corp., Madison, WI). 3-bp mutations were introduced into CD11d-(Ϫ173/ϩ74)-luc with the QuikChange mutagenesis system (Stratagene, La Jolla, CA). The mouse SM22␣ promoter (Ϫ445 to ϩ65, GenBank TM accession no. U36589), the human TGF␤1 promoter (Ϫ323 to ϩ11, GenBank TM accession no. J04431), and the human AP-2␣ promoter (Ϫ390 to ϩ1, GenBank TM accession no. X95235) were prepared by the polymerase chain reaction (PCR) and cloned into pGL3-Basic. Expression plasmids pCMV4-Sp1/flu and pCMV4-Sp3/flu were generously provided by Dr. J. M. Horowitz (23, 24) . Full-length GKLF (GenBank TM accession no. NM004235), GKLFa (GenBank TM accession no. BC030811), which contains an additional 102 bp of DNA in-frame and immediately upstream of the zinc finger region in GKLF, KLF5 (GenBank TM accession no. BC42131), KLF6 (GenBank TM accession no. BC000311), and KLF9 (GenBank TM accession no. NM_001206) cDNAs were amplified by the PCR from human spleen Quick-Clone cDNA (Clontech, Palo Alto, CA) and cloned into the expression plasmid pCMV-HA (Clontech). Plasmids pCMV-HA-GKLFa⌬ZF, pCMV-HASp1⌬ZF, and pCMV-HA-TIEG1⌬ZF, which are deleted in their zinc finger (ZF) DNA binding domains, were prepared by the PCR using the full-length cDNA clones as templates.
Transient Transfection and Reporter
Assays-Approximately 1 ϫ 10 7 cells were co-transfected with 10 g of a firefly luc reporter plasmid, 5 g of an expression plasmid when used, and 2 g of Renilla luc plasmid pRL-SV40 (Promega) as described (15) . Luciferase activity was measured 24 h post-transfection and normalized against Renilla luciferase or against the total protein in the cells.
Stable Transfection-To integrate the wt CD11d-(Ϫ173/ϩ74)-luc reporter or those containing 3-bp mutations at the Ϫ61 or Ϫ51 site into the genome of THP1, 1 ϫ 10 7 cells were co-transfected with 5 g each of linearized reporter plasmid and linearized pSV40/Zeo (Invitrogen Life Technologies, Carlsbad, CA) as described (15) . The cells were grown for 48 h in complete RPMI medium and plated onto complete RPMI medium containing 0.9% methylcellulose and 500 g/ml Zeocin (Invitrogen Life Technologies). After 15 days, individual colonies were picked and maintained as pools of 5 clones each that were expanded and transiently transfected with the pCMV-HA expression constructs.
Electrophoretic Mobility Shift Analysis (EMSA)-EMSA was performed as described (25) . The DNA probes containing 3-bp mutations (bolded) within the Ϫ66 to Ϫ40 region of the CD11d promoter were: wt, 5Ј-CCACGCCCCTCCTACCCACTGTGCCC-3Ј, Ϫ66 to Ϫ40 wild-type region; M1, 5Ј-AACCGCCCCTCCTACCCACTGTGCCC-3Ј; M2, 5Ј-CC-ACGAAACTCCTACCCACTGTGCCCC-3Ј; M3, 5Ј-CCACGCCCCTAA-GACCCACTGTGCCCC-3Ј; M4, 5Ј-CCACGCCCCTCCTAAAAACTGT-GCCCC-3Ј; M5, 5Ј-CCACGCCCCTCCTACCCACGTGGCCCC-3Ј; and M6, 5Ј-CCACGCCCCTCCTACCCACTGTGAAAC-3Ј. The ␥-32 P-labeled probes were incubated with either nuclear extract, purified Sp1 protein (Promega Corp), or purified GST-GKLFa as described (18, 20) .
Reverse Transcriptase (RT)-PCR and Western Blotting-Total RNA from cells was isolated using the RNeasy Mini Kit (Qiagen Inc.). RT-PCR was performed using the Omniscript RT kit (Qiagen Inc.) and Advantage DNase I footprint analysis is underlined with a gray box. B, a schematic of GKLFa, a longer isoform of GKLF that was identified in a yeast one-hybrid screen, shows the additional 102 bp that is inserted in-frame with the zinc finger region. The numbering in the schematic corresponds to that in the NCBI accession sequence. C, a series of labeled oligonucleotide probes (M1-6) containing 3-bp mutations (bolded) throughout the Ϫ66 to Ϫ40 region that were used in EMSA are shown. The wt probe was included as control. D, purified GST-GKLFa, GST, and Sp1 proteins were incubated with the oligonucleotide probes. Filled arrowheads show the GST-GKLFa or Sp1 protein-probe complexes. E, nuclear extract protein from THP1, Jurkat, and IM9 cells was incubated with the oligonucleotide probes. Filled arrowheads show the GKLF/GKLFa or Sp1 protein-probe complexes, which were identified by including either anti-GKLF antibodies (Ab:GKLF) or anti-Sp1 antibodies (Ab:Sp1) into binding reactions with the wild-type probe. The anti-GKLF antibodies do not distinguish between GKLF and GKLFa (see Fig. 5B ). The Sp1-specific complex is supershifted with anti-Sp1 antibodies (empty arrow), whereas formation of the GKLF/GKLFa-specific complex is blocked by anti-GKLF antibodies (filled arrow).
2 PCR kit (Clontech). Western blotting was performed as described (26) using anti-HA or anti-GKLF antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in the primary incubation reaction.
Chromatin Immunoprecipitation (ChIP)-ChIP assays were performed using the ChIP Assay kit (Upstate Biotechnology, Inc., Lake Placid, NY) as described (20) . Briefly, genomic DNA was cross-linked to bound nuclear proteins in vivo, sheared, and the cross-links were reversed on an aliquot that served as input DNA. Proteins still bound to the DNA were immunoprecipitated with anti-GKLF, anti-Sp1, anti-HDAC-1, anti-HDAC-2 (Santa Cruz Biotechnology), or anti-TIEG1 antibodies generously provided by Dr. T. C. Spelsberg (27, 28) . Genomic DNA from THP1 cells that were stably transfected with the CD11d-(Ϫ173/ϩ74)-luc reporters and subsequently transiently transfected with the HA-tagged expression constructs was immunoprecipitated with anti-HA antibodies. As controls, DNA was immunoprecipitated with non-immune antisera or no antibodies. Input and immunoprecipitated DNA was subjected to semiquantitative PCR using primers specific to the Ϫ200 to Ϫ20 or Ϫ712 to Ϫ520 region of the CD11d promoter as described (20) . To differentiate between HA-tagged proteins bound to the endogenous CD11d promoter and the integrated CD11d-(Ϫ173/ ϩ74)-luc reporters, primers specific to the CD11d-luc fusion were used. The PCR cycling parameters were as follows: 1 min at 95°C, 30 s at 60°C, 1 min at 72°C, for 30 cycles. Samples were also analyzed at 21, 24, 27, 30, 36, and 39 cycles of amplification to verify linearity. The PCR products were separated by gel electrophoresis, stained with Vistra Green, and quantitated on a Storm Phosphorimager. Binding of each transcription factor is the amount of PCR product derived from each immunoprecipitated DNA expressed relative to that of the appropriate input DNA. Binding of KLF5 (29), KLF6 (30) , and KLF9 (31) to the SM22␣ promoter, TGF␤1 promoter, and AP-2␣ promoter, respectively, was assessed with the appropriate antibody (Santa Cruz Biotechnology) in conjunction with the following primers: SM22␣ mouse promoter/ Ϫ225 to Ϫ64 region, 5Ј-CCCGCAGCATCTCCAAAGCATGCAG-3Ј (forward primer); 5Ј-AGTGATGTCACCCCTCTGCCGTGG-3Ј (reverse primer); TGF␤1 human promoter/Ϫ272 to Ϫ62 region, 5Ј-TGGCGCTT-GGCCGCCAGGAGGCAG-3Ј (forward primer); and 5Ј-CGGGGACCGG-CTGGGTCGGCAGGG-3Ј(reverse primer); AP-2␣ human promoter/-390 to Ϫ214 region, 5Ј-AAAGGGCAGCTCGGATCGTGGTAG-3Ј (forward primer); and 5Ј-CTCCGCCGCGAGGCCCTGCCCCAA-3Ј (reverse primer).
Small Interfering RNA (siRNA) Silencing of GKLF and Lung Kruppel-like Factor 2-GKLF siRNA corresponding to nucleotides 528 -881 of the GKLF sequence (GenBank TM accession no. NM002235) was prepared by PCR essentially as described (32) using a kit from the manufacturer (Ambion Inc., Austin, TX). THP1 and HL60 cells were electroporated at 300 V, 125 microfarads with 0.6 or 1.2 g of siRNA as described (32) incubated in 15 ml of complete RPMI medium for 48 h and harvested. RT-PCR was performed with primers to GKLF, CD11d, Sp1, or glyceraldehyde-phosphate dehydrogenase (GAPDH), and the PCR products were stained with Vistra Green and quantitated on a Storm Phosphorimager. Expression of each gene was determined relative to GAPDH. The PCRs were analyzed at 21, 24, 27, 30, 36, and 39 cycles to monitor linearity.
RESULTS

GKLF Binds to a Site That Overlaps the Sp1 Binding
Site-We previously showed that CD11d is controlled by Sp proteins, and in vivo DNase I footprint analysis revealed that one or more proteins, presumably Sp proteins, occupy the Ϫ66 to Ϫ38 region of the CD11d promoter ( Fig. 1A) (15) . In preliminary experiments, site-directed mutagenesis of the Ϫ54 to Ϫ44 region suggested that a putative repressor protein might interact. 2 To isolate the putative repressor and possibly other transcription factors that interact adjacent to this region, a yeast one-hybrid screen of a spleen cDNA expression library was employed using a yeast strain in which were integrated four copies of the Ϫ100 to Ϫ20 region fused upstream of the his3 and lacZ genes as bait. BLAST analysis of the one-hybrid clones selected on 45 mM 3-AT revealed one clone that corresponded to 2 J. D. Noti, unpublished observations.
FIG. 2. GKLF and GKLFa repress the CD11d promoter.
A, THP1, HL60, Jurkat, and IM-9 cells were cotransfected with CD11d-(Ϫ173/ϩ74)-luc and 5 g each of either the GKLF or GKLFa mammalian expression plasmid pCMV-HA-GKLF or pCMV-HA-GKLFa. Luciferase expression from CD11d-(Ϫ173/ϩ74)-luc cotransfected with the empty plasmid pCMV-HA (None) in all cell lines 24 h post-transfection is set at 100%. The mean luciferase activities Ϯ S.D. are indicated after normalization to either total protein (CD11d/protein) or Renilla luciferase expressed from the co-transfected pTK-RL plasmid (CD11d/Renilla). This was done because, on occasion, expression from pTK-RL in transfected IM9 cells appeared to be down-regulated through a cryptic site on this plasmid, which, when used as means to normalize for differences in transfection efficiencies, appears to skew the results by masking potential repression of the CD11d promoter by the Kruppel-like proteins. B, THP1 and Jurkat cells were cotransfected with CD11d-(Ϫ173/ϩ74)-luc (wt) or luciferase reporters which contain the 3-bp mutations at Ϫ65, Ϫ61, Ϫ55, Ϫ51, Ϫ46, or Ϫ42, that were analyzed in the EMSA (Fig. 1C) and 5 g each of either pCMV-HA (None), pCMV-HA-GKLF (GKLF), pCMV-HAGKLFa (GKLFa), or pCMV4-Sp1/flu (Sp1). Luciferase expression from CD11d-(Ϫ173/ϩ74)-luc co-transfected with the empty plasmid pCMV-HA 24 h posttransfection is set at 100%. The mean luciferase activities Ϯ S.D. are indicated after normalization to Renilla luciferase. a longer isoform of GKLF that we refer to as GKLFa (Fig. 1B) . The GKLFa protein contains an additional 102-bp sequence inserted in-frame and immediately upstream of the zinc finger region (Fig. 1B) .
The Ϫ66 to Ϫ40 region of the CD11d promoter contains a GC-rich sequence that resembles the binding site for members of the Sp and Kruppel-like families and was examined further by EMSA. Purified GST-GKLFa efficiently bound the wild-type probe to the Ϫ66 to Ϫ40 region, but not to probes containing mutations at Ϫ55, Ϫ51, Ϫ46, and Ϫ61 (Fig. 1, C and D) . Binding of GST-GKLF yielded the same binding pattern. 2 Mutations at Ϫ61 and Ϫ55 prevented Sp1 from binding (Fig. 1D) .
EMSA was also performed using nuclear extract protein from THP1, Jurkat, and IM-9 cell lines and yielded essentially the same results with one exception (Fig. 1E) . In extracts from IM-9 cells, loss of Sp1 binding to probes containing mutations at Ϫ51 and Ϫ46 was also observed. It should be noted that these results do not allow us to conclude whether GKLF or GKLFa (or both) are bound. Overall, these results indicate that GKLF/GKLFa binds a longer and overlapping site shared by Sp1.
GKLF/GKLFa Down-regulates the CD11d Promoter in Both Myeloid and Non-myeloid Cells-Co-transfections of pCMV-HA-GKLF or pCMV-HA-GKLFa along with CD11d-(Ϫ173/ ϩ74)-luc showed that both forms of this Kruppel-like protein (GKLF/GKLFa) significantly repressed luciferase expression from the CD11d promoter in both myeloid and non-myeloid cells ( Fig. 2A) . GKLF/GKLFa also was able to repress luciferase expression from reporters containing 3-bp mutations (the same ones introduced into the EMSA probes) at Ϫ65 or Ϫ42 (Fig.  2B) . In contrast, mutations at Ϫ55 and Ϫ46 resulted in an increase in luciferase expression that was unable to be repressed by GKLF/GKLFa and show that these sites are essential for GKLF/GKLFa to functionally interact. The mutations at Ϫ61 and Ϫ51 resulted in a significant reduction of luciferase expression in the absence of co-transfected GKLF/GKLFa and suggest that a transcriptional activator(s) is prevented from binding. In THP1 cells, one of these activators is Sp1 as evidenced by the inability of cotransfected Sp1 to increase luciferase expression from a reporter containing the Ϫ61 mutation (Fig. 2B ) and the other is TIEG1 that we recently reported activates CD11d (32) . The inability of GKLF/GKLFa to further repress luciferase expression of the Ϫ61 and Ϫ51 mutant reporters is consistent with the results of the EMSA (Fig. 1 ) that indicate these sites are also essential for binding. Further, the sites essential for binding of Sp1 revealed in the EMSA (Ϫ61 and Ϫ55) are also the sites essential for co-transfected Sp1 to interact in THP1 cells (Fig. 2B) .
Expression of Endogenous CD11d in Myeloid Cells Is Upregulated by siRNA That Targets GKLF/GKLFa-In vivo, upregulation of CD11d expression occurred in response to decreased expression of GKLF/GKLFa mRNA and protein by GKLF siRNA in both THP1 and HL60 cells (Fig. 3A) . Linearity of the PCRs was confirmed by analyzing samples within a range of cycles (Fig. 3B) and expression of GAPDH was used to normalize expression of GKLF/GKLFa and CD11d (Fig. 3D).   FIG. 3 . GKLF/GKLFa siRNA up-regulates CD11d expression. A, increasing amounts (g) of GKLF siRNA were added to THP1 or HL60 cells to down-regulate expression of GKLF and GKLFa. As control, the effect of random siRNA was determined. The PCR (30 cycles) was performed to assess expression of GKLF/GKLFa, CD11d, Sp1, and GAPDH. A representative gel stained with ethidium bromide is shown. Western blot analysis of GKLF/GKLFa and GAPDH protein levels in siRNA-treated and random siRNA-treated cells confirmed that GKLF/ GKLFa was downregulated. B, the above PCR analysis at 30 cycles was confirmed to be within the linear range of amplification. The accumulation of GKLF/GKLFa, CD11d, Sp1, and GAPDH PCR products following 21-39 cycles of amplification of reverse-transcribed RNA isolated from THP1 cells not exposed to siRNA or to cells exposed to 0.6 g or 1.2 g of GKLF siRNA is shown. For plotting purposes, expression of GKLF/ GKLFa, Sp1, and GAPDH after 39 cycles of amplification of RNA isolated from THP1 cells not exposed to siRNA (No siRNA) was set at 100% in the appropriate graph, whereas, expression of CD11d in THP1 cells exposed to 1.2 g of GKLF siRNA (GKLF siRNA) was set at 100%. The linearity of the PCR reaction was also confirmed during the analysis of HL60 cells but is not shown. C, for semiquantitation, the PCR products were stained with Vistra Green, analyzed on a Storm Phosphorimager, and the results are shown graphically. Expression of GKLF/ GKLFa and CD11d was first normalized to GAPDH for each concentration of siRNA used. For plotting purposes, the expression of GKLF/GKLFa in THP1 and HL60 cells not exposed to siRNA is set at 100%, whereas, expression of CD11d in THP1 and HL60 cells exposed to 1.2 g of GKLF siRNA is set at 100%. The values (Relative %) represent the mean Ϯ S.D. obtained from two independent experiments done in duplicate.
Transfection of THP1 and HL60 cells with 1.2 g of GKLF siRNA led to a 455% increase and 475% increase, respectively, in CD11d expression over that seen in cells not treated with siRNA (Fig. 3D) . No significant change in expression of Sp1 was evident in either cell line transfected with GKLF siRNA and control experiments show that overall gene expression was unaffected by random siRNAs (Fig. 3A) . These results indicate that in myeloid cells expression of GKLF/GKLFa is essential for repression of CD11d.
GKLF/GKLFa Is Expressed in Myeloid and Non-myeloid Cells-Maximal CD11d expression occurs in fully differentiated primary myeloid cells and in myeloid cell lines induced to differentiate with PMA. RT-PCR assays were performed to determine whether differences in GKLF/GKLFa and Sp1 expression account for this differential expression. Assessment of CD11d expression in HL60 and THP1 cells showed the characteristic biphasic response to PMA in that a shorter exposure (24 h (Fig. 4A) . Expression of Sp1 was approximately the same in myeloid and non-myeloid cells and not affected by PMA (Fig. 4B) . Combined GKLF/GKLFa expression was modestly higher in the myeloid cell lines and was essentially unchanged in any cell line stimulated with PMA (Fig. 4B) . Further, GKLF/GKLFa protein levels were essentially unaffected by PMA (Fig. 4B) . To determine which forms of GKLF were expressed, primers internal or flanking the 102-bp insert in GKLFa were used in a second RT-PCR analysis (Fig. 4C) . If both forms of GKLF are expressed in these cell lines, primer pair ac should yield a 510-bp and 408-bp PCR product that correspond to GKLFa, and if only GKLFa is present, primer pair bc should yield a 380-bp PCR product (Fig. 4C) . Analysis of THP1 cells showed the presence of both GKLF and GKLFa, with GKLF as the predominant form. Interestingly, PMA induces GKLFa, although its level is still lower than GKLF (Fig. 4C) . GKLFa also responds similarly to PMA in the other cell lines. 2 GKLFa is also present in spleen cells from which the one-hybrid library was constructed although it is not the predominant form. Although GKLFa expression rises in response to PMA, the presence of both forms of GKLF in these cells does not allow us to conclude whether the reduced expression of CD11d during the biphasic response is due simply to increased expression of either of these isoforms.
Up-regulation of CD11d in Differentiated Myeloid Cells Is Associated with Loss of GKLF/GKLFa Binding in Vivo-ChIP
assays were done using anti-GKLF antibodies to determine whether differential occupancy of the CD11d promoter by GKLF/GKLFa accounts for the differential expression of this promoter in response to PMA (Fig. 5A) . The ChIP results reflect the total amount of GKLF and GKLFa bound in vivo as the anti-GKLF antibodies react with both forms in a Western blot (Fig. 4B) . ChIP analysis of the CD11d promoter was initially investigated on myeloid and non-myeloid cells that were either unstimulated or stimulated with 100 nM PMA for 48 h. The PCRs (Fig. 5A) were done within the linear range of amplification as indicated by analysis of samples over a range of cycles (Fig. 5C ). ChIP analysis revealed that the amount of GKLF/ GKLFa bound to the Ϫ200 to Ϫ20 region of the CD11d promoter in PMA-stimulated THP1 and HL60 cells was significantly reduced compared with the amount bound in unstimulated cells (Fig. 5, A and C) . In contrast, essentially no change was seen in the amount of bound GKLF/GKLFa in PMA-stimulated IM-9 or Jurkat cells (Fig. 5A) . As control, genomic DNA was mock-immunoprecipitated in the absence of antibody and no PCR product was found (Fig. 5A) . Primers spanning the Ϫ712 to Ϫ520 region of the CD11d promoter, which is not expected to interact with GKF/GKLFa, amplified all input DNAs but produced no PCR product from any of the immunoprecipitated genomic DNAs (Fig. 5A) . The amount of Sp1 bound to the Ϫ200 to Ϫ20 region in PMA-stimulated THP1 and HL60 cells was also reduced compared with the amount bound in unstimulated cells (Fig. 5, A and C) . In contrast, PMA stimulation did not alter the amount of Sp1 bound in IM9 and Jurkat cells (Fig. 5A) . Taken together, these results indicate that expression of CD11d following differentiation of myeloid cells by 48-h exposure to 100 nM PMA involves a significant release of GKLF/GKLFa from the CD11d promoter and partial release of Sp1.
Down-regulation of CD11d in Myeloid Cells during the Biphasic Response Is Associated with Loss of Sp1 Binding in
Vivo-ChIP assays were done to examine the mechanism for the initial down-regulation of CD11d in myeloid cells exposed to 10 mM PMA for 24 h (Fig. 5D) . Analysis of THP1 and HL60 Expression of GAPDH mRNA served as control and amplification was adjusted to be in the linear range. Western blot analysis of GKLF/GKLFa protein expression in these cells was also performed. C, to determine which forms of GKLF were expressed in B, two primer pairs were used in a RT-PCR analysis of THP1 cells. The schematic shows that one primer pair (ac) flanked the 102-bp insert in GKLFa and would yield a 510-bp product with GKLFa as template and a 408-bp product with GKLF as template. A second primer pair (bc) is specific to the 102-bp insert and would yield a 380-bp product with GKLFa. Amplification of spleen cDNA and plasmids containing either GKLF (plasmid GKLF) or GKLFa (plasmid GKLFa) served as controls for comparative purposes. The molecular weight markers (MW) used in each gel were either the 1-kb Stratagene ladder (A) or the 1-kb NEB ladder (B and C). cells showed that Sp1 binding to the Ϫ200 to Ϫ20 region initially decreased ϳ90% after exposure to 10 nM PMA for 24 h, whereas no significant change in GKLF/GKLFa binding was observed during this period (Fig. 5D) . Following exposure of THP1 and HL60 to 100 nM PMA for 48 h, the level of Sp1 binding increased but was still below that observed in unstimulated cells as was already shown above (Fig. 5A) . In contrast, Sp1 binding to CD11d in IM-9 cells was essentially unchanged following exposure to PMA (Fig. 5, A and D) . Thus, the downregulation of CD11d expression during the biphasic response to PMA can be attributed, in part, to loss of Sp1 binding.
The Response of CD11d to GKLF/GKLFa Is Specific-To determine if the repression of CD11d is specific to GKLF/ GKLFa, potential interactions of the CD11d promoter with other Kruppel-like proteins were examined (Fig. 6) . RT-PCR analysis showed that a variety of Kruppel-like proteins are expressed at various levels in myeloid and non-myeloid cell lines (Fig. 6A) . KLF5, KLF6, and KLF9, which are highly and ubiquitously expressed in these cell lines, were examined further. ChIP analysis showed binding of KLF5, KLF6, and KLF9 to their respective promoter targets SM22␣, TGF␤1, and AP-2␣ (29 -31) however none are bound to the CD11d promoter in either unstimulated or PMA-stimulated THP1 cells (Fig. 6B) . Co-expression of KLF5, KLF6, or KLF9 in THP1 cells transfected with CD11d-(Ϫ173/ϩ74)-luc did not affect luciferase expression, indicating that these factors do not functionally interact with CD11d (Fig. 6C) . Control experiments demonstrated proper activation by KLF5, KLF6, and KLF9 of the known promoter targets, SM22␣-luc, TGF␤1-luc, and AP-2␣-luc, respectively (Fig. 6C) .
GKLF/GKLFa Directly Binds the CD11d Promoter in Vivo and Recruits HDACs 1 and 2 to the Promoter-In
ChIP analysis, formaldehyde treatment of cells leads to the formation of protein-DNA adducts and also protein-protein adducts, raising the possibility that GKLF/GKLFa and/or Sp1 are indirectly bound to the CD11d promoter via interaction with a partner protein that is directly bound. Further, if GKLF/GKLFa and Sp1 are indeed directly bound, it is not clear whether they FIG. 5 . Prolonged exposure of myeloid cells to PMA leads to reduced GKLF/GKLFa and Sp1 binding to CD11d. A, proteins bound in vivo to the CD11d promoter were detected by ChIP analysis of genomic DNA from THP1, HL60, IM-9, and Jurkat cells either unstimulated (0) or stimulated with 100 nM PMA for 48 h (48). Genomic DNA was cross-linked to bound proteins in vivo with formaldehyde, sheared, and precipitated with anti-GKLF (GKLF) or anti-Sp1 (Sp1) antibodies, and amplified by the PCR with primers specific to the Ϫ200 to Ϫ20 region. Amplification of cross-linked genomic DNA that was precipitated in the absence of antibodies (No Ab) is shown. Genomic DNA that was not cross-linked (Input) was also amplified by PCR. The quantity of each input DNA was initially determined by OD 260/280 and adjusted if necessary to yield approximately the same amount of PCR product for the four cell lines. A representative gel stained with ethidium bromide is shown. As control, amplification of the Ϫ712 to Ϫ520 region of the CD11d promoter following immunoprecipitation was done. For semiquantitation, the PCR products were stained with Vistra Green and analyzed on a Storm Phosphorimager. B, Western blot analysis shows that anti-GKLF antibodies can detect purified GST-GKLF (GST-GKLF) and GST-GKLFa (GST-GKLFa) proteins and a single band at 55 kDa corresponding to the endogenous GKLF and GKLFa proteins in THP1 cells. The results show that the antibodies do not differentiate between GKLF and GKLFa, and therefore, the results in A reflect the total amount of these proteins that are bound. C, the above PCR analysis at 30 cycles was confirmed to be within the linear range by monitoring the PCR through 21-39 cycles of amplification. The accumulation of input, Sp1, and GKLF/GKLFa PCR products following 21-39 cycles of amplification of reverse-transcribed RNA isolated from unstimulated (ϪPMA) and PMA-stimulated (ϩPMA) THP1 cells is shown. The yield of PCR product (Relative %) after amplification of input and immunoprecipitated DNAs from unstimulated THP1 cells for 30 cycles was set at 100%. The linearity of the PCR reaction was also confirmed during the analysis of the other cell lines but is not shown. The results represent the mean Ϯ S.D. from two independent experiments done in duplicate. D, Sp1 binding is reduced prior to release of GKLF/GKLFa from the CD11d promoter. Proteins bound in vivo to the CD11d promoter were detected by ChIP analysis of genomic DNA from THP1, HL60, and IM-9 cells either unstimulated (0) or stimulated with 10 nM PMA for 24 h (24), or 100 nM PMA for 48 h (48). Immunoprecipitation and PCR analysis of the Ϫ200 to Ϫ20 region is as described above. Amplification of cross-linked genomic DNA that was precipitated following exposure to non-immune sera (Non-immune) is also shown. The results represent the mean Ϯ S.D. from two independent experiments done in duplicate.
interact at the same sites essential for their binding in EMSA (Fig. 1D) . To address these possibilities, GST fusion proteins lacking the zinc finger (⌬ZF) DNA binding domains of GKLF, GKLFa, Sp1, and TIEG1 (which also interacts within the Ϫ66 to Ϫ40 region (32)), were first assessed in EMSA. As shown (Fig. 7A) , GST-GKLF⌬ZF, GST-GKLFa⌬ZF, GST-Sp1⌬ZF, and GST-TIEG1⌬ZF were unable to bind the Ϫ66 to Ϫ40 region directly (Fig. 7A) or indirectly via tethering to any of the fulllength GST-fusion proteins. 2 Expression constructs lacking zinc fingers GKLF⌬ZF, GKLFa⌬ZF, Sp1⌬ZF, and TIEG1⌬ZF, had no effect on luciferase expression when co-transfected individually with CD11d-(Ϫ173/ϩ74)-luc into THP1 cells (Fig.  7B) or with any of their full-length counterparts. 2 HA-tagged GKLF, GKLFa, Sp1, or TIEG1 were then transfected into THP1 cells stably integrated with the CD11d-(Ϫ173/ϩ74)luc reporter or with reporters containing 3-bp mutations at either the Ϫ61 or Ϫ51 site followed by ChIP analysis to assess binding in vivo. Only the full-length HA-tagged GKLF, GKLFa, Sp1, and TIEG1 proteins, but not the zinc finger-deleted proteins, were bound to THP1 genomic DNA immunoprecipitated with anti-HA antibodies and amplified with primers specific to the CD11d-luc fusion (Fig. 7C) . Mutation of the Ϫ51 site prevented HA-tagged GKLF, GKLFa, and TIEG1 but not Sp1 from binding to the CD11d-luc fusion, whereas mutation of the Ϫ61 site prevented all four from binding (Fig. 7C) . The results argue against a mechanism whereby GKLF/GKLFa, Sp1, or TIEG1 bind indirectly to CD11d via tethering to directly bound proteins since the integrated copy of the CD11d-luc fusion, like the endogenous CD11d promoter, is presumably bound by endogenous GKLF/ GKLFa, Sp1, TIEG1, and other uncharacterized proteins, and would have been expected to provide a scaffold to bind the zinc-finger deleted proteins. These results are also consistent with the EMSA (Fig. 1, C and D) and further indicate that the Kruppel-like proteins bind to a larger site that overlaps that for Sp1.
To determine if GKLF/GKLFa represses CD11d expression by recruiting HDACs, we asked whether GKLF/GKLFa can physically interact with HDACs in vitro. As shown (Fig. 7D) , anti-GKLF antibodies were able to immunoprecipitate not only GKLF but also HDAC1 and HDAC2 from THP1 nuclear extracts. Further, when GST-GKLFa was spiked into the THP1 nuclear extract, anti-GST antibodies immunoprecipitated not only GST-GKLFa but also HDAC1 and HDAC2 (Fig. 7D) . ChIP analysis performed on THP1 cells stably transfected with the CD11d-(Ϫ173/ϩ74)-luc reporter plasmid revealed that in addition to GKLF/GKLFa and Sp1, HDAC1 and HDAC2 were also associated with the Ϫ200 to Ϫ20 region of the CD11d promoter in unstimulated THP1 cells but not in cells stimulated with 100 nM PMA for 48 h (Fig. 7E) . Mutation of the Ϫ51 site revealed that Sp1 but not GKLF/GKLFa, HDAC1, or HDAC2 was bound. Taken together, the results indicate that HDAC1 and HDAC2 are associated in close proximity and possibly tethered to GKLF/GKLFa bound at the Ϫ51 site, and when bound participate in repression of CD11d.
DISCUSSION
Using a yeast one-hybrid screen we identified a longer isoform of GKLF that can bind to and repress the CD11d promoter. GKLF can inhibit DNA synthesis and growth arrest (22, 33, 34) and repress or activate transcription (29, (35) (36) (37) (38) (39) (40) (41) . GKLF and the longer isoform, GKLFa, are present in myeloid cells; however, we were unable to determine if one form preferentially regulates CD11d in vivo.
Initially (within 24 h) PMA down-regulates CD11d expression in myeloid cells (15) , but longer exposure (48 h) leads to its up-regulation (21) . In the earlier study, we concluded that Sp1 and/or Sp3 occupy the Ϫ66 to Ϫ38 region of the CD11d promoter to mediate basal expression in all cell types (15) . Using in vivo footprint analysis, loss of protein occupancy at the Ϫ66 to Ϫ38 region was demonstrated preferentially in myeloid cells exposed to 10 nM PMA for 24 h, leading us to conclude that loss of Sp protein binding led to down-regulation of CD11d expression (15) . ChIP assays performed herein afford a more enlightened view and reveal that GKLF/GKLFa and Sp1, are co-bound (or exist in an equilibrium to allow sharing of the site). Exposure of myeloid cells to 10 nM PMA for 24 h leads to a significant loss of Sp1 but not GKLF/GKLFa from the CD11d promoter. In contrast, binding of GKLF/GKLFa to the promoter significantly decreases while Sp1 increases following exposure to 100 nM PMA for 48 h. In addition to Sp1, we recently reported increased binding of another transcriptional activator, TIEG1, to the CD11d promoter in myeloid cells exposed to 100 nM PMA for 48 h (20) . The subsequent up-regulation of CD11d expression following inhibition of GKLF/GKLFa expression with siRNA also supports a repressor role for this protein. However, an alternative interpretation is that GKLF siRNA affects expression of another transcription factor that, in turn, directly regulates CD11d.
Rather than utilizing distinct sites on the CD11d promoter to bind transcriptional activators and repressors, it appears that GKLF/GKLFa, TIEG1, and Sp1 bind a common site. Similar opposing effects on gene expression from the CYP1A1 (40) and CD1 (41) promoters by GKLF and Sp1 have been reported. Antagonistic regulation between pairs of Kruppel-like proteins including GKLF/IKLF (29, 36) and KLF9/KLF10 (31) as a result of mutually exclusive binding has also been shown. ChIP analysis indicates that GKLF/GKLFa and Sp1 are co-bound in an equilibrium that is regulated by PMA. An alternative interpretation is that PMA does not synchronously activate the CD11d promoter in all cells. In this scenario, some cells would have only Sp1 bound, whereas others would have only GKLF/ GKLFa bound. Analysis of genomic DNA from such a heterogeneous population of cells would thus lead to the conclusion that the proteins are co-bound.
Another Kruppel-like protein, ZBP-89, was recently reported to regulate the CD11b gene (42) . ZBP-89, originally identified from a rat pituitary adenoma cell line using a GC-rich element as probe (43) , is expressed in a variety of tissues, functions as a repressor of the genes for gastrin (43) and vimentin (44) and apparently physically interacts with Sp1 to repress vimentin expression (44) . Interestingly, during differentiation of myeloid FIG. 7 . GKLF/GKLFa is directly bound to the CD11d promoter and in close proximity to associated HDACs. A, full-length wt (GST-TIEG1, GST-GKLF, GST-GKLFa, GST-Sp1, or GST fusion proteins lacking their zinc finger DNA binding domains (⌬ZF) were incubated with the Ϫ66 to Ϫ40 region oligonucleotide probe. Filled arrowheads show the specific protein-probe complexes. B, full-length HA-tagged GKLF, GKLFa, Sp1, and TIEG1 expression constructs (GKLF, GKLFa, Sp1, TIEG1) or their respective constructs lacking zinc fingers (⌬ZF) were each co-transfected along with CD11d-(Ϫ173/ϩ74)-luc into THP1 cells. Luciferase expression was determined as described in Fig. 6 . C, full-length HAtagged GKLF, GKLFa, Sp1, and TIEG1 expression constructs or their respective constructs lacking zinc fingers ((⌬ZF) were each co-transfected into THP1 cells stably-transfected with either the CD11d-(Ϫ173/ϩ74)-luc reporter (wtCD11d-luc) or with reporters containing 3-bp mutations (Fig. 1C) at either the Ϫ61 site (Ϫ61/CD11d-luc) or the Ϫ51 site (Ϫ51/CD11d-luc). Genomic DNA was immunoprecipitated with anti-HA antibodies (HA), or non-immune sera (NI) for ChIP analysis. D, the immunoprecipitating antibodies (IP Ab) added to nuclear extract (NE) from THP1 cells or nuclear extract spiked with GST-GKLFa were anti-GKLF antibodies (GKLF), anti-GST antibodies (GST), or non-immune antisera (NI) antibodies. The immunoprecipitates were analyzed by Western blot with anti-GKLF, anti-HDAC1, and anti-HDAC2 antibodies. E, ChIP analysis was performed on THP1 cells stably-transfected with the CD11d-(Ϫ173/ϩ74)-luc reporter (wtCD11d-luc) or with the reporter containing the 3-bp mutation (Fig. 1C) at the Ϫ51 site (-51CD11d-luc). Genomic DNA was immunoprecipitated with anti-Sp1 (Sp1), anti-GKLF (GKLF), anti-HDAC1 (HDAC1), anti-HDAC2 (HDAC2), anti-TIEG1 (TIEG1) antibodies or non-immune sera (NI). THP1 cells were either unstimulated (No PMA) or stimulated with 100 nM PMA for 48 (ϩPMA). cells with PMA, ZBP-89, and CD11b expression increases in parallel, suggesting that ZBP-89 does not repress CD11b expression in the early stage of myeloid differentiation (42) . In contrast, the drop in CD11b expression following later stage differentiation of monocytes to macrophages correlates with an increase in ZBP-89 level. These authors concluded that ZBP-89 exerts its activity at a later stage of differentiation. However, these authors note that qualitative changes to ZBP-89 may prevent its accessibility to the CD11b promoter during early myeloid differentiation. A similar scenario may explain the lack of a clear inverse correlation of GKLF/GKLFa and CD11d expression following PMA stimulation of myeloid cells in our study. It is possible that following PMA stimulation, GKLF/ GKLFa becomes modified resulting in a reduced affinity for the CD11d promoter as indicated in the ChIP assays.
Chromatin remodeling is a central theme in gene regulation in which "open" chromatin conformations are associated with histone hyperacetylation and gene activation, whereas "closed" chromatin conformations are associated with histone deacetylation and gene repression (45, 46) . Recruitment of histone acetyltransferases (HATs) or histone deacetylases (HDACs) involves their interaction with transcriptional activators and coactivators or repressors and corepressors (47) (48) (49) . It was recently reported that GKLF in association with HDAC1 inhibits expression of the cyclin B1 promoter (45, 49, 50) and erythroid Kruppel-like factor can act as a transcriptional repressor through interaction with the corepressors mSin3A and HDAC1 (51) . Consistent with the concept that Kruppel-like factors can interact with HDACs to mediate repression was the finding that HDAC1, HDAC2, and GKLF/GKLFa are closely associated with the CD11d promoter in unstimulated THP1 cells but not after exposure of THP1 cells to PMA that results in upregulation of CD11d. The finding that HDAC1 and HDAC2 physically associate with GKLFa in vitro is supportive of a hypothesis that GKLF/GKLFa recruits these HDACs to form a repressor complex. A detailed study of potential interactions among GKLF/GKLFa, Sp1, and TIEG1 and other as yet unidentified proteins will provide exciting information about the mechanisms of CD11d expression and may shed light on how the other leukocyte integrins are regulated.
